82 related articles for article (PubMed ID: 27403717)
1. How the Intrinsically Disordered N-Terminus of Cancer/Testis Antigen MAGEA10 Is Responsible for Its Expression, Nuclear Localisation and Aberrant Migration.
Samel A; Väärtnõu F; Verk L; Kurg K; Mutso M; Kurg R
Biomolecules; 2023 Nov; 13(12):. PubMed ID: 38136576
[TBL] [Abstract][Full Text] [Related]
2. Production of Oral Vaccines Based on Virus-Like Particles Pseudotyped with Protozoan-Surface Proteins.
Rupil LL; Del Carmen Serradell M; Luján HD
Methods Mol Biol; 2022; 2410():503-537. PubMed ID: 34914065
[TBL] [Abstract][Full Text] [Related]
3. Selective Isolation of Retroviruses from Extracellular Vesicles by Intact Virion Immunoprecipitation.
Renner TM; Bélanger K; Langlois MA
Bio Protoc; 2018 Sep; 8(17):e3005. PubMed ID: 34395797
[TBL] [Abstract][Full Text] [Related]
4. MAGEA4 Coated Extracellular Vesicles Are Stable and Can Be Assembled In Vitro.
Reinsalu O; Samel A; Niemeister E; Kurg R
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069064
[TBL] [Abstract][Full Text] [Related]
5. Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus.
Fontana D; Garay E; Cervera L; Kratje R; Prieto C; Gòdia F
Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33809060
[TBL] [Abstract][Full Text] [Related]
6. Cancer-testis antigens MAGEA proteins are incorporated into extracellular vesicles released by cells.
Kuldkepp A; Karakai M; Toomsoo E; Reinsalu O; Kurg R
Oncotarget; 2019 Jun; 10(38):3694-3708. PubMed ID: 31217903
[TBL] [Abstract][Full Text] [Related]
7. Synthetic biology for bioengineering virus-like particle vaccines.
Charlton Hume HK; Vidigal J; Carrondo MJT; Middelberg APJ; Roldão A; Lua LHL
Biotechnol Bioeng; 2019 Apr; 116(4):919-935. PubMed ID: 30597533
[TBL] [Abstract][Full Text] [Related]
8. Keap1-MCM3 interaction is a potential coordinator of molecular machineries of antioxidant response and genomic DNA replication in metazoa.
Tamberg N; Tahk S; Koit S; Kristjuhan K; Kasvandik S; Kristjuhan A; Ilves I
Sci Rep; 2018 Aug; 8(1):12136. PubMed ID: 30108253
[TBL] [Abstract][Full Text] [Related]
9. Antibody response against cancer-testis antigens MAGEA4 and MAGEA10 in patients with melanoma.
Õunap K; Kurg K; Võsa L; Maiväli Ü; Teras M; Planken A; Ustav M; Kurg R
Oncol Lett; 2018 Jul; 16(1):211-218. PubMed ID: 29928403
[TBL] [Abstract][Full Text] [Related]
10. Distinct Particle Morphologies Revealed through Comparative Parallel Analyses of Retrovirus-Like Particles.
Martin JL; Cao S; Maldonado JO; Zhang W; Mansky LM
J Virol; 2016 Sep; 90(18):8074-84. PubMed ID: 27356903
[TBL] [Abstract][Full Text] [Related]
11. MAGE-A family: attractive targets for cancer immunotherapy.
Sang M; Lian Y; Zhou X; Shan B
Vaccine; 2011 Nov; 29(47):8496-500. PubMed ID: 21933694
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens.
Kurg R; Reinsalu O; Jagur S; Õunap K; Võsa L; Kasvandik S; Padari K; Gildemann K; Ustav M
Sci Rep; 2016 Jul; 6():29425. PubMed ID: 27403717
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes pathogenesis is modulated by spontaneous autoimmune responses to endogenous retrovirus antigens in NOD mice.
Bashratyan R; Regn D; Rahman MJ; Marquardt K; Fink E; Hu WY; Elder JH; Binley J; Sherman LA; Dai YD
Eur J Immunol; 2017 Mar; 47(3):575-584. PubMed ID: 28083937
[TBL] [Abstract][Full Text] [Related]
14. Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.
Venereo-Sánchez A; Fulton K; Koczka K; Twine S; Chahal P; Ansorge S; Gilbert R; Henry O; Kamen A
Vaccine; 2019 Nov; 37(47):7100-7107. PubMed ID: 31358407
[TBL] [Abstract][Full Text] [Related]
15. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
Bouamr F; Garnier L; Rayne F; Verna A; Rebeyrotte N; Cerutti M; Mamoun RZ
Virology; 2000 Dec; 278(2):597-609. PubMed ID: 11118382
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
